Vaccine maker Bavarian Nordic expects the incoming Trump administration to boost biodefence funding despite the nomination of ...

"Bavarian Nordic shares sink by 12% after mpox sales slump in Q3" was originally created and published by Pharmaceutical ...

Bavarian Nordic A/S ( (BVNRY) ) has released its Q3 earnings. Here is a breakdown of the information Bavarian Nordic A/S presented to its ...

Bavarian Nordic AS (BVNKF) reports robust travel health business growth and strategic advancements in vaccine launches amid ...

Danish biotech Bavarian Nordic said on Friday the order book for delivery of its vaccine for mpox and smallpox in 2025 ...

Bavarian Nordic, a maker of the mpox vaccine, on Friday said the incoming Trump administration may present opportunities even ...

Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...

Reversing an earlier decision, European regulators recommended that the Alzheimer’s therapy Leqembi should be approved ...

Bavarian Nordic AS (OCSE:BAVA) is set to release its Q3 2024 earnings on Nov 15, 2024. The consensus estimate for Q3 2024 ...

Current health news highlights include calls to reduce mpox test prices, CDC confirming Oregon's bird flu case, Eyenovia's ...

President-elect Donald Trump's selection of vaccine skeptic Robert F. Kennedy Jr. as health secretary weighed on global ...

COPENHAGEN, Denmark, November 15, 2024 – (OMX: BAVA) announced today its interim financial results for the first nine months ...